Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- 最新申報
- 2024/11/14
2023 年第 1 季持倉
持倉截至 2023/3/31，2023/5/15 申報。只含多頭部位，變化是跟 2022 年第 4 季比股數。
- 持股檔數
- 52
- 較 2022 年第 4 季 +17
- 總值
- $2.64 億
- 較 2022 年第 4 季 +$3,010 萬 (+12.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| TGTXTG Therapeutics, Inc. | COM | 1,100,000 | $1,654 萬 | 6.3% | +1,100,000 | 新進 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 475,000 | $1,394 萬 | 5.3% | +125,000+35.7% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 225,000 | $1,388 萬 | 5.3% | −10,000−4.3% | 減碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 110,000 | $1,179 萬 | 4.5% | −20,000−15.4% | 減碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 164,620 | $1,086 萬 | 4.1% | −135,380−45.1% | 減碼 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 275,000 | $1,052 萬 | 4.0% | +190,000+223.5% | 加碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 600,000 | $999.0 萬 | 3.8% | +300,000+100.0% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 225,000 | $843.3 萬 | 3.2% | +65,000+40.6% | 加碼 | 歷史 |
| CTICCti Biopharma Corp | COM | 2,000,000 | $840.0 萬 | 3.2% | +150,000+8.1% | 加碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 60,000 | $827.0 萬 | 3.1% | +5,000+9.1% | 加碼 | 歷史 |
| PFEPfizer Inc | Stock | 200,000 | $816.0 萬 | 3.1% | +200,000 | 新進 | 歷史 |
| RVNCRevance Therapeutics, Inc. | COM | 250,000 | $805.3 萬 | 3.0% | −50,000−16.7% | 減碼 | 歷史 |
| JNJJohnson & Johnson | Stock | 50,000 | $775.0 萬 | 2.9% | +50,000 | 新進 | 歷史 |
| QUREuniQure N.V. | SHS | 375,000 | $755.3 萬 | 2.9% | +375,000 | 新進 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 30,000 | $726.8 萬 | 2.7% | +10,000+50.0% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 200,000 | $715.8 萬 | 2.7% | +200,000 | 新進 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 325,000 | $686.4 萬 | 2.6% | +175,000+116.7% | 加碼 | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 70,000 | $636.4 萬 | 2.4% | −430,000−86.0% | 減碼 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,000,000 | $611.0 萬 | 2.3% | −300,000−23.1% | 減碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 450,000 | $598.5 萬 | 2.3% | 00.0% | 不變 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 550,000 | $593.5 萬 | 2.2% | −250,000−31.3% | 減碼 | 歷史 |
| INCYIncyte Corp | COM | 75,000 | $542.0 萬 | 2.1% | +75,000 | 新進 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 475,000 | $526.8 萬 | 2.0% | +475,000 | 新進 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 140,000 | $520.5 萬 | 2.0% | −60,000−30.0% | 減碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 225,000 | $517.5 萬 | 2.0% | +225,000 | 新進 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 175,000 | $445.2 萬 | 1.7% | +10,000+6.1% | 加碼 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 175,000 | $425.8 萬 | 1.6% | −275,000−61.1% | 減碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 195,000 | $417.1 萬 | 1.6% | +195,000 | 新進 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 200,000 | $403.4 萬 | 1.5% | +65,000+48.1% | 加碼 | 歷史 |
| BMEABiomea Fusion, Inc. | COM | 120,000 | $372.1 萬 | 1.4% | +120,000 | 新進 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 425,000 | $343.8 萬 | 1.3% | +425,000 | 新進 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 17,500 | $317.9 萬 | 1.2% | −22,500−56.3% | 減碼 | 歷史 |
| ETNB89bio, Inc. | COM | 200,000 | $304.6 萬 | 1.2% | +200,000 | 新進 | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 275,000 | $229.4 萬 | 0.9% | +50,000+22.2% | 加碼 | 歷史 |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 250,000 | $223.0 萬 | 0.8% | +250,000 | 新進 | 歷史 |
| Rain Oncology Inc.75082Q105 | COM | 250,000 | $218.5 萬 | 0.8% | +250,000 | 新進 | – |
| IRONDisc Medicine, Inc. | COM | 100,000 | $211.9 萬 | 0.8% | +100,000 | 新進 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 125,000 | $191.9 萬 | 0.7% | +25,000+25.0% | 加碼 | – |
| RXDXPrometheus Biosciences, Inc. | COM | 15,000 | $161.0 萬 | 0.6% | +5,104+51.6% | 加碼 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 200,000 | $154.4 萬 | 0.6% | +200,000 | 新進 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 75,000 | $136.8 萬 | 0.5% | +75,000 | 新進 | 歷史 |
| FUSNFusion Pharmaceuticals Inc. | COM | 350,000 | $132.0 萬 | 0.5% | +350,000 | 新進 | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 150,000 | $108.6 萬 | 0.4% | +60,000+66.7% | 加碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 80,000 | $100.6 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| GERNGeron Corp | COM | 450,000 | $97.7 萬 | 0.4% | +450,000 | 新進 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM | 850,000 | $74.0 萬 | 0.3% | −150,000−15.0% | 減碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 27,578 | $71.0 萬 | 0.3% | +27,578 | 新進 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 175,000 | $54.8 萬 | 0.2% | −164,907−48.5% | 減碼 | 歷史 |
| KYNBKyntra Bio, Inc. | COM | 26,500 | $49.4 萬 | 0.2% | +26,500 | 新進 | 歷史 |
| IMGNImmunoGen, Inc. | COM | 124,977 | $48.0 萬 | 0.2% | +124,977 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 25,000 | $41.5 萬 | 0.2% | +25,000 | 新進 | 歷史 |
| VNDAVanda Pharmaceuticals Inc. | COM | 12,500 | $8.50 萬 | <0.1% | +12,500 | 新進 | 歷史 |
選擇權（6 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2022 年第 4 季之後清倉（7 檔）
2022 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 4 季股數 | 2022 年第 4 季市值 | 2022 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| Invesco QQQ Trust Series I46090E103 | ETF | 50,000 | $1,331 萬 | 5.7% | – |
| SGENSeagen Inc. | COM | 85,000 | $1,092 萬 | 4.7% | 歷史 |
| PRVBProvention Bio, Inc. | COM | 400,000 | $422.8 萬 | 1.8% | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 125,000 | $247.5 萬 | 1.1% | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 20,000 | $87.6 萬 | 0.4% | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 82,853 | $85.0 萬 | 0.4% | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM | 800,000 | $36.0 萬 | 0.2% | 歷史 |